Blow to Modi govt as Interpol gives clean chit to Dr Zakir Naik, cancels red corner notice

Chikkamgaluru, Feb 21: Wazi Noronha, aka, Vojald, the father of Amulya Leona Noronha, who lives in Koppa taluk of Chickmagalur district has said that he was shocked by his daughter’s pro-Pakistan slogans.

“Let her rot in jail. I don’t mind if police break her bones, I don’t support what she said and I will not approach lawyers for her bail. She has committed a grave mistake,” he said.

Amulya, a 19-year-old student activist, was booked for sedition yesterday after she raised ‘Long Live Pakistan’ slogans at a CAA-NRC rally. A visibly embarrassed Asaduddin Owaisi, AIMIM chief and MP tried to snatch the mic away from her and slammed her. Karnataka Police have registered a case under IPC Section 124A (Offence of sedition) against Amulya.

Mr. Wazi, who owns a two-acre areca plantation and runs a poultry farm, said he would not make any attempts to get her bail. “Let the law take its course. I cannot approve of her statement,” he said.

He said he had cautioned his daughter against getting involved in protests. “I told her to complete studies first and later she could fight for poor people. But what she said yesterday is not acceptable. I don’t know what made her so. I hope a probe would bring out who prompted her to make such statements,” he said.

Mr. Wazi also admitted that he was associated with BJP and had worked for saffronite leaders like Shobha Karandlaje and D N Jeevaraj.

Mangaluru, Feb 1: Rotary Club of Mangalore city team represented by Rtn. Dr. Ranjan Rao and Rtn. Sumith Rao duo bagged the 14th Annual prestigious Rotary Quiz Trophy by securing 380 points. The Rotary Club of Vijayanagar Mysore represented by  Rtn. H.M. Harish secured 370 points and was declared runners up.

Rotary Club of Mangaluru central as a part of Rotary movement awareness campaign conducted their 14th Annual “Dist. Level Inter Club Rotary Quiz”  contest on Friday 31.01.2020 at Hotel Ocean Pearl Hall, Mangaluru. The Quiz was based exclusively on Rotary related affairs, matters and issues.

Chamarajnagar City based Eminent Pediatrician and Rotary past Dist. Governor Rtn. Dr.R. Nagarajun  graced the occasion as Chief Guest, in is address he lauded the  invaluable contributions of Dr. Rai to the Rotary Movement and congratulated on his achievements.  Later he awarded the Rotary Glittering Trophy, Certificates and Cash prizes of R.3,000 to the Winners and Runners up and congratulated them on their unique achievements.

13 Teams from Mangaluru, Bykampady, Panamburu, Deralaktte, Puttur, Mysore, participated in this contest. Rtn. Dr. Devdas Rai was the Quiz Master and officiated the closely contested  quiz contest. Asst. Governor Zone-2  Rtn. Geethanand Pai was the guest of honour he released the weekly club news bulletin “Centor”. Club President Rtn. Dr. Jayaprakash Poonja presided over the function. Secretary Rtn. K.M. Hegde presented the monthly report. Rtn. Prakash Chandra proposed the vote of thanks.  The event was sponsored by Chairman and Managing Director of Athena Hospital Rtn. Raviraj Shettiyan and Eminent Chartered Accountant C.A. Nithin Shetty.

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.